Solo Outpatient Hematology/Oncology Opportunity – Infusion Center Focus
Job at a glance
Job description
We are seeking a Board-Eligible or Board-Certified Hematologist/Oncologist to provide comprehensive outpatient care in a hospital-based chemotherapy and infusion center.
This is a solo provider role supported by an experienced mid-level provider and a full clinical staff. The physician will oversee both the Hematology/Oncology clinic and Infusion Services, with on-site presence required for all infusion treatments.
Position Highlights
-
Outpatient chemotherapy and infusion center
-
Solo provider model with mid-level support
-
Hospital consults required with call
-
Collaborates directly with ER physicians and hospitalists for admissions
-
Full nursing and administrative support team
Schedule & Assignment Details
-
Schedule: Monday–Friday, 8:00 AM – 5:00 PM
-
Start Date: February 16–20 (possible ongoing coverage)
-
Setting: Hospital-based outpatient practice
-
Location: Northern California
Clinical Responsibilities
-
Diagnosis, staging, precision medicine, symptom management, and treatment of Hematology/Oncology patients
-
Physician oversight of:
-
Oncology/Hematology clinic
-
Infusion services
-
-
Infusion services include:
-
Chemotherapy & Immunotherapy
-
Blood and platelet transfusions
-
Hormone therapy
-
Antibiotic therapy
-
Rheumatoid arthritis injections
-
Therapeutic phlebotomies
-
Patient Volume
-
Admissions per day: 15–20
-
Patients per day: 15–20
-
Case Mix: All tumor types (Hematology & Oncology)
EMR
-
Clinic: iKnowMed
-
Infusion Center: Cerner
Support Staff
-
1 Clinic RN
-
2 Medical Assistants
-
2 Front Office Clerks
-
1 Quality Analyst/Billing Specialist
-
10 Infusion RNs
Credentialing
-
Timeframe: 30–60 days
Requirements (Must-Have)
-
Board Eligible or Board Certified in Hematology and Oncology
-
Fellowship trained
-
Active California Medical License
-
DEA
-
ACLS (required if requesting Moderate Sedation privileges)
-
NPDB Self-Query report dated within 30 days of submission
Reason for Coverage
-
Provider shortage